| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |